Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

BUY
$1.52 - $2.8 $602,714 - $1.11 Million
396,523 Added 2382.95%
413,163 $913,000
Q1 2023

May 15, 2023

SELL
$1.37 - $2.54 $3,718 - $6,893
-2,714 Reduced 14.02%
16,640 $42,000
Q4 2022

Feb 14, 2023

SELL
$1.67 - $2.51 $474,300 - $712,870
-284,012 Reduced 93.62%
19,354 $36,000
Q3 2022

Nov 14, 2022

BUY
$1.96 - $2.93 $409,465 - $612,109
208,911 Added 221.18%
303,366 $780,000
Q2 2022

Aug 15, 2022

BUY
$1.73 - $3.09 $85,757 - $153,174
49,571 Added 110.44%
94,455 $182,000
Q1 2022

May 16, 2022

SELL
$2.94 - $4.77 $76,525 - $124,158
-26,029 Reduced 36.71%
44,884 $133,000
Q4 2021

Feb 14, 2022

BUY
$4.07 - $5.3 $241,049 - $313,897
59,226 Added 506.77%
70,913 $318,000
Q3 2021

Nov 15, 2021

SELL
$4.7 - $7.24 $733,660 - $1.13 Million
-156,098 Reduced 93.03%
11,687 $57,000
Q2 2021

Aug 16, 2021

SELL
$6.81 - $10.93 $1.69 Million - $2.72 Million
-248,744 Reduced 59.72%
167,785 $1.14 Million
Q1 2021

May 17, 2021

BUY
$6.14 - $8.31 $602,997 - $816,108
98,208 Added 30.85%
416,529 $2.94 Million
Q4 2020

Feb 16, 2021

BUY
$4.58 - $7.14 $356,653 - $556,006
77,872 Added 32.39%
318,321 $1.99 Million
Q3 2020

Nov 16, 2020

BUY
$4.19 - $6.69 $487,028 - $777,618
116,236 Added 93.58%
240,449 $1.3 Million
Q2 2020

Aug 14, 2020

BUY
$2.97 - $5.22 $368,912 - $648,391
124,213 New
124,213 $648,000
Q1 2020

May 15, 2020

SELL
$2.67 - $4.97 $328,949 - $612,313
-123,202 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$2.93 - $4.5 $360,981 - $554,409
123,202 New
123,202 $497,000
Q2 2019

Aug 14, 2019

SELL
$3.47 - $6.32 $66,037 - $120,275
-19,031 Closed
0 $0
Q1 2019

May 15, 2019

SELL
$5.36 - $7.24 $323,331 - $436,738
-60,323 Reduced 76.02%
19,031 $102,000
Q4 2018

Feb 14, 2019

SELL
$4.8 - $11.6 $365,683 - $883,734
-76,184 Reduced 48.98%
79,354 $407,000
Q3 2018

Nov 14, 2018

BUY
$9.05 - $10.95 $1.41 Million - $1.7 Million
155,538 New
155,538 $1.51 Million

Others Institutions Holding PRTK

About Paratek Pharmaceuticals, Inc.


  • Ticker PRTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,862,500
  • Description
  • Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectru...
More about PRTK
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.